Talk:Breast cancer–related regulator of tp53
project page for more information. | ||
Low | This article has been rated as Low-importance on the importance scale. |
Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks. | ||
??? | This article has not yet received a rating on the importance scale. | |
This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance). |
On 24 July 2020, it was proposed that this article be moved from Breast cancer-related regulator of tp53 to Breast cancer–related regulator of tp53. The result of the discussion was moved. |
Requested move 24 July 2020
- The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.
The result of the move request was: moved per
MOS:SUFFIXDASH, and consistency with other articles. —usernamekiran (talk) 09:43, 5 August 2020 (UTC)
]
- Breast cancer-related regulator of tp53 → Breast cancer–related regulator of tp53
- Critical illness-related corticosteroid insufficiency → Critical illness–related corticosteroid insufficiency
- Cystic fibrosis-related diabetes → Cystic fibrosis–related diabetes
- HIV disease-related drug reaction → HIV disease–related drug reaction
- Urotensin II-related peptide → Urotensin II–related peptide
- Xenotropic murine leukemia virus-related virus → Xenotropic murine leukemia virus–related virus
– Per
Talk:Severe acute respiratory syndrome–related coronavirus. —BarrelProof (talk) 01:37, 24 July 2020 (UTC)
]
- The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.